Ubidecarenone may slow progression of Parkinson's disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1361, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa and Parkinson's disease progression

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Simple interventions can slow the progression of chronic kidney disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 5, 2005-05 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite

Pardoprunox monotherapy may provide benefit for patients with early-stage Parkinson's disease

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antioxidants slow atherosclerotic progression

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite